Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Related Articles by Review for PubMed (Select 11956737)

1.

Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.

Manzoni M, Rollini M.

Appl Microbiol Biotechnol. 2002 Apr;58(5):555-64. Epub 2002 Feb 14. Review.

PMID:
11956737
2.

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.

Lennernäs H, Fager G.

Clin Pharmacokinet. 1997 May;32(5):403-25. Review.

PMID:
9160173
3.

Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Istvan ES.

Am Heart J. 2002 Dec;144(6 Suppl):S27-32. Review.

PMID:
12486413
4.

Biotechnological production and applications of statins.

Barrios-González J, Miranda RU.

Appl Microbiol Biotechnol. 2010 Jan;85(4):869-83. doi: 10.1007/s00253-009-2239-6. Epub 2009 Oct 10. Review.

PMID:
19820926
5.

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.

Schachter M.

Fundam Clin Pharmacol. 2005 Feb;19(1):117-25. Review.

PMID:
15660968
6.
7.

Comparing HMG-CoA reductase inhibitors.

Jones PH.

Clin Cardiol. 2003 Jan;26(1 Suppl 1):I15-20. Review.

PMID:
12539818
8.

Treating hypercholesterolemia: looking forward.

Gotto AM Jr.

Clin Cardiol. 2003 Jan;26(1 Suppl 1):I21-8. Review.

PMID:
12539819
9.

Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals.

Rosanoff A, Seelig MS.

J Am Coll Nutr. 2004 Oct;23(5):501S-505S. Review.

PMID:
15466951
10.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
11.

Discovery, biochemistry and biology of lovastatin.

Alberts AW.

Am J Cardiol. 1988 Nov 11;62(15):10J-15J. Review.

PMID:
3055919
12.

The clinical relevance of low-density-lipoproteins size modulation by statins.

Rizzo M, Berneis K.

Cardiovasc Drugs Ther. 2006 Jun;20(3):205-17. Review.

PMID:
16775666
13.

New dimension of statin action on ApoB atherogenicity.

Chapman MJ, Caslake M, Packard C, McTaggart F.

Clin Cardiol. 2003 Jan;26(1 Suppl 1):I7-10. Review.

PMID:
12539816
14.

Effects of atorvastatin on the different phases of atherogenesis.

Rubba P.

Drugs. 2007;67 Suppl 1:17-27. Review.

PMID:
17910518
15.

Pleiotropic effects of HMG-CoA reductase inhibitors.

Bocan TM.

Curr Opin Investig Drugs. 2002 Sep;3(9):1312-7. Review.

PMID:
12498006
16.

Modulation of the inflammatory process by statins.

Crisby M.

Drugs Today (Barc). 2003 Feb;39(2):137-43. Review.

PMID:
12698208
17.

Compactin-a review.

Chakravarti R, Sahai V.

Appl Microbiol Biotechnol. 2004 Jun;64(5):618-24. Epub 2004 Mar 19. Review.

PMID:
15034683
18.

Pleiotropic effects of statins and related pharmacological experimental approaches.

Alegret M, Silvestre JS.

Methods Find Exp Clin Pharmacol. 2006 Nov;28(9):627-56. Review.

PMID:
17200729
19.

Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.

Krysiak R, Okopień B, Herman Z.

Drugs. 2003;63(17):1821-54. Review.

PMID:
12921488
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk